Angiotensinkonvertierendes Enzym 2 (ACE2): Rolle in der Pathogenese von Erkrankungen außerhalb von COVID-19
Authors:
- 9 April 2021
- journal article
- editorial
- Published by Springer Nature in Der Nephrologe
- Vol. 16 (3) , 185-188
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Renin–Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress SyndromeInternational Journal of Molecular Sciences, 2020
- Interaction between the apelinergic system and ACE2 in the cardiovascular system: therapeutic implicationsClinical Science, 2020
- An update on ACE2 amplification and its therapeutic potentialActa Physiologica, 2020
- The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)Physiological Reviews, 2018
- Role of the ACE2/Angiotensin 1–7 Axis of the Renin–Angiotensin System in Heart FailureCirculation Research, 2016
- ACE and ACE2 in kidney diseaseWorld Journal of Nephrology, 2015
- Angiotensin-Converting Enzyme 2 (ACE2) in Disease PathogenesisCirculation Journal, 2010
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular EventsNew England Journal of Medicine, 2008
- A Human Homolog of Angiotensin-converting EnzymeJournal of Biological Chemistry, 2000
- A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9Circulation Research, 2000